REQUEST A DEMO
Total
USD $0.00
Search more companies

Novartis Korea Limited (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Novartis Korea Limited Profile Updated: October 27, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Novartis Korea Limited is engaged in developing, manufacturing and distribution of various pharmaceutical products. The company offers medicines used to treat/cure hypertension, dementia, leukemia, diabetes, Parkinson's disease, cancer, osteoporosis, and diseases involving cardiovascular, central nervous system, skin/metabolic, respiratory, eye, and transplanted immune diseases. Novartis Korea Limited also offers vaccines and miscellaneous products like contact lenses and lens care products. The company is based in Seoul, South Korea. Novartis Korea Limited was incorporated in 1984 and operates as a subsidiary of Novartis AG.

Headquarters
49th Floor, 10, Gukjegeumyung-ro Yeongdeungpo-gu Seoul
Seoul; Seoul;

Contact Details: Purchase the Novartis Korea Limited report to view the information.

Website: http://www.novartis.co.kr

Basic Information
Total Employees:
Purchase the Novartis Korea Limited report to view the information.
Outstanding Shares:
Purchase the Novartis Korea Limited report to view the information.
Registered Capital:
Purchase the Novartis Korea Limited report to view the information.
Incorporation Date:
September 20, 1984
Key Executives
Purchase this report to view the information.
Chairman
Ownership Details
Purchase this report to view the information.
78.6%
Purchase this report to view the information.
21.4%
Subsidiaries
Sandoz Korea Ltd.
Company Performance
Financial values in the chart are available after Novartis Korea Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
11.78%
Total operating revenue
11.78%
Operating profit (EBIT)
34%
EBITDA
19.95%
Net Profit (Loss) for the Period
-78.69%
Total assets
-4.59%
Total equity
8.95%
Operating Profit Margin (ROS)
0.13%
Net Profit Margin
-7.02%
Return on Equity (ROE)
-33.77%
Debt to Equity Ratio
-1.89%
Quick Ratio
-0.17%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?